North Korea rejected AstraZeneca’s Covid-19 vaccine over side effects: Report – News Vibe24

    North Korea rejected AstraZeneca's Covid-19 vaccine over side effects: Report - Times of India
    SEOUL: SEOUL: North Korea has rejected planned shipments of AstraZeneca Covid-19 vaccine under the global COVAX distribution system due to concerns about side effects, according to the South Korean.
    COVAX has said it will supply nearly 2 million doses of AstraZeneca shots to North Korea. The first batch was expected in late May but was delayed amid protracted consultations, South Korea said last month.
    North Korea has not reported cases of Covid-19, a position disputed by South Korean and US officials. The exclusive country, however, has imposed strict anti-virus measures, including closed borders and internal travel restrictions.
    According to a report by the National Security Strategy Institute (INSS), which is affiliated with South Korea’s spy agency, Pyongyang is now considering other vaccine options.
    The World Alliance for Vaccines and Immunization, one of COVAX’s leading organizations, did not immediately respond to a request for comment from Reuters.
    The INSS report also said that North Korea is not interested in Chinese vaccines due to concerns that they may not be as effective, but has shown interest in shooting in Russia, hoping that they will be donated for free.
    “It is leaning towards the Russian vaccine, but no adjustments have been made,” Lee Sang-keun, director of strategic research for the Korean Peninsula at INSS, told Reuters, citing anonymous sources.
    On Wednesday, Russian Foreign Minister Sergei Lavrov said Moscow had offered vaccinations to Pyongyang on several occasions.
    Lee added that North Korean authorities were concerned about the AstraZeneca vaccine following reports of rare but severe blood clots in some people who received it.
    While North Korea has allowed its diplomats abroad to take Covid-19 shots since late March, it is not trying to secure vaccines for domestic use, the INSS said.


    Newsvibe24 Source